Form 4/A for ATEX Anterix Inc.
Accepted 2026-09-11 16:08:59 ET · period of report 2026-09-08 · accession 0001669943-26-000021 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DMA | 2026-09-11 16:08 | 2026-09-08 | ATEX | Ashe Gena L | CLO, Corp Sec | S - Sale+OE | $85.44 | -4,357 | 9,238 | -32% | -$372.3K |
| DA | 2026-09-11 16:08 | 2026-09-08 | ATEX | Ashe Gena L | CLO, Corp Sec | M - OptEx | $34.96 | +6,833 | 16.1K | +74% | +$238.9K |
| DA | 2026-09-11 16:08 | 2026-09-08 | ATEX | Ashe Gena L | CLO, Corp Sec | F - Tax | $86.27 | -2,769 | 13.3K | -17% | -$238.9K |
| DA | 2026-09-11 16:08 | 2026-09-08 | ATEX | Ashe Gena L | CLO, Corp Sec | M - OptEx | $0.00 | -6,833 | 35.7K | -16% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-09-08 | S | D | 293 | $85.44 | 9,238 | D | — | — | |
| 2 | Common | Common Stock | 2026-09-08 | M | A | 6,833 | $34.96 | 16,071 | D | — | — | |
| 3 | Common | Common Stock | 2026-09-08 | F | D | 2,769 | $86.27 | 13,302 | D | — | — | (F1) The Reporting Person exercised a stock option to purchase 6,833 shares of the Issuer's Common Stock for $34.96 per share and paid the exercise price on a cashless basis, resulting in the Issuer withholding an aggregate of 2,769 shares of the Issuer's Common Stock subject to the stock option to pay the exercise price and to satisfy its income tax withholding and remittance obligations in connection with the exercise of the stock option. The withholding of shares referenced here does not involve an open market sale of stock. |
| 4 | Common | Common Stock | 2026-09-08 | S | D | 4,064 | $85.44 | 9,238 | D | — | — | |
| 5 | Derivative | Stock Option (Right to Buy) | 2026-09-08 | M | D | 6,833 | $0.00 | 35,658 | D | $34.96 · — to 2035-05-20 | 6,833 Common Stock | (F2) The option shares subject to this option shall vest and become exercisable in three equal annual installments, with 1/3 of the option shares vesting and becoming exercisable on May 20, 2026, and with the remaining option shares vesting and becoming exercisable in 2 equal annual installments thereafter. |